NO-donating NSAIDs and cancer: An overview with a note on whether NO is required for their action
- 29 April 2008
- journal article
- review article
- Published by Elsevier BV in Nitric Oxide
- Vol. 19 (2), 199-204
- https://doi.org/10.1016/j.niox.2008.04.022
Abstract
No abstract availableKeywords
This publication has 58 references indexed in Scilit:
- Synthesis, nitric oxide release, and anti-leukemic activity of glutathione-activated nitric oxide prodrugs: Structural analogues of PABA/NO, an anti-cancer lead compoundBioorganic & Medicinal Chemistry, 2008
- NO-donating aspirin inhibits the activation of NF-κB in human cancer cell lines and Min miceCarcinogenesis: Integrative Cancer Research, 2008
- Study of molecular mechanisms of pro-apoptotic activity of NCX 4040, a novel nitric oxide-releasing aspirin, in colon cancer cell linesJournal of Translational Medicine, 2007
- JS-K, a GST-activated nitric oxide generator, induces DNA double-strand breaks, activates DNA damage response pathways, and induces apoptosis in vitro and in vivo in human multiple myeloma cellsBlood, 2007
- O2-Acetoxymethyl-protected diazeniumdiolate-based NSAIDs (NONO–NSAIDs): Synthesis, nitric oxide release, and biological evaluation studiesBioorganic & Medicinal Chemistry, 2007
- The mechanism of action of nitric oxide-donating aspirinBiochemical and Biophysical Research Communications, 2007
- Molecular characterization of cytotoxic and resistance mechanisms induced by NCX 4040, a novel NO-NSAID, in pancreatic cancer cell lines*Apoptosis, 2006
- In Vitro Metabolism of (Nitrooxy)butyl Ester Nitric Oxide-Releasing Compounds: Comparison with Glyceryl TrinitrateJournal of Pharmacology and Experimental Therapeutics, 2006
- Nitric oxide release and distribution following oral and intraperitoneal administration of nitroaspirin (NCX 4016) in the ratLife Sciences, 2004
- NO-donating aspirin inhibits intestinal carcinogenesis in Min (APCMin/+) miceBiochemical and Biophysical Research Communications, 2003